A new age of genetic screening is coming — and we don’t have any rules for it
By Dalton Conley,
The Washington Post
| 06. 14. 2021
New ‘polygenic’ screening techniques open a Pandora’s Box of ethical issues.
After the coronavirus baby bust is over and fertility clinics are booming again, increasing numbers of new parents will bring home a generation of infants prescreened to perform better at school or basketball, resist heart disease or be less likely to have schizophrenia.
It may not be common yet, but the ability to screen embryos for any number of traits is here now, and improving every day. And this brave new world of genetic prediction I’m describing is not just about selecting babies during in vitro fertilization. It could also involve life insurance companies swabbing your cheek before issuing you a policy, preschools and colleges scoring your DNA as part of their admissions process and dating sites asking for your genetic profile before offering you a match.
But with this new technology comes countless ethical questions. Is embryo selection a good thing or a bad thing — or both? How do we balance potential inequities created against potential lives saved or improved? Do we want to keep genetics from becoming destiny, and what does that even mean? We desperately need...
Related Articles
By Katie Hunt, CNN | 07.30.2025
Scientists are exploring ways to mimic the origins of human life without two fundamental components: sperm and egg.
They are coaxing clusters of stem cells – programmable cells that can transform into many different specialized cell types – to form...
By Rob Stein, NPR [cites CGS' Katie Hasson] | 08.06.2025
A Chinese scientist horrified the world in 2018 when he revealed he had secretly engineered the birth of the world's first gene-edited babies.
His work was reviled as reckless and unethical because, among other reasons, gene-editing was so new...
By Arthur Caplan and James Tabery, Scientific American | 07.28.2025
An understandable ethics outcry greeted the June announcement of a software platform that offers aspiring parents “genetic optimization” of their embryos. Touted by Nucleus Genomics’ CEO Kian Sadeghi, the $5,999 service, dubbed “Nucleus Embryo,” promised optimization of...
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...